Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Atazanavir Treatment on Endothelial Dysfunction, Vascular Inflammation and Heme Oxygenase Activity in Type 2 Diabetes Mellitus

NCT00696722 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00696722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00696722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Atazanavir Treatment on Endothelial Dysfunction, Vascular Inflammation and Heme Oxygenase Activity in Type 2 Diabetes Mellitus
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2008
Completion date
March 31, 2009
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus related endothelial dysfunction